Back to Search
ANTONIO OMURO, MD
MD
Neurology Physician
NPI: 1912175134IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
ME131052(FL)247562(NY)62031(CT)SFP51(CA)
CMS Specialties
PrimaryNEUROLOGY
Education
OTHER
Class of 1994
Research & Publications (20)
Exploring multi-targeting strategies for the treatment of gliomas.
PMID 19037835·Curr Opin Investig Drugs·2008
6-review
Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial.
PMID 16614943·J Neurooncol·2006
3-trial
Ventriculoperitoneal shunt in patients with leptomeningeal metastasis.
PMID 15883329·Neurology·2005
8-other
Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.
PMID 15642906·Neurology·2005
3-trial
High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib.
PMID 15844174·Cancer·2005
8-other
Delayed neurotoxicity in primary central nervous system lymphoma.
PMID 16216945·Arch Neurol·2005
8-other
What is the place of bevacizumab and irinotecan in the treatment of glioblastoma and other malignant gliomas?
PMID 18989118·Curr Opin Neurol·2008
8-other
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.
PMID 17987262·J Neurooncol·2008
3-trial
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
PMID 18936428·Neurology·2008
4-observational
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
PMID 18413641·J Clin Oncol·2008
3-trial
What is the relevance of determining EGFR-variant-III status in glioblastomas?
PMID 18319741·Nat Clin Pract Oncol·2008
8-other
Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882).
PMID 18248979·Eur J Cancer·2008
3-trial
Molecular genetic markers as predictors of response to chemotherapy in gliomas.
PMID 17906460·Curr Opin Oncol·2007
6-review
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
PMID 17896079·J Neurooncol·2007
3-trial
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
PMID 17804469·Ann Oncol·2007
4-observational
Is single-agent temozolomide the treatment of choice for recurrent primary central nervous system lymphoma?
PMID 17622233·Nat Clin Pract Oncol·2007
8-other
Lessons learned in the development of targeted therapy for malignant gliomas.
PMID 17620423·Mol Cancer Ther·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 35 Park St Fl 8
New Haven, CT 06519 - Phone
- (203) 200-1638
Quick Facts
- NPI
- 1912175134
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile